About Vantis Vascular
Vantis Vascular is a private company based in San Jose, California. It has reported $41,710,564 raised in six offerings on Form D since December 2018. Its chief executive is Jason Turner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Jul 10, 2026 | $18,639,500of $21.5M target | 123 | $151K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 30, 2024 | Oct 10, 2024 | $14,338,798of $22.1M target | 114 | $125K | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2022 | Feb 4, 2022 | $7,043,766of $8.0M target | 73 | $96,490 | EquityRule 506(b) | Form D ↗ |
| Aug 23, 2021 | Sep 7, 2021 | $503,500of $800K target | 17 | $29,618 | DebtRule 506(b) | Form D ↗ |
| Dec 1, 2020 | Dec 14, 2020 | $700,000of $1.0M target | 20 | $35,000 | EquityRule 506(b) | Form D ↗ |
| Dec 7, 2018 | Dec 18, 2018 | $485,000of $1.7M target | 14 | $34,643 | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $41,710,564 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vantis Vascular's Form D filed Jul 10, 2026.
LP
Len Pinchuk
Director
Tim Fischell
Chief Medical Officer and director
Also an executive officer and director at Ablative Solutions and a director at Aseko.
